Idecabtagene vicleucel Disease Interactions
There are 2 disease interactions with idecabtagene vicleucel.
Idecabtagene vicleucel (applies to idecabtagene vicleucel) infection
Major Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral
Idecabtagene vicleucel should not be administered to patients with active infection or inflammatory disorders. Signs and symptoms of infection should be monitored before and during treatment. Additionally, screening for cytomegalovirus infection (CMV), hepatitis B and C and HIV should be performed before treatment initiation. Viral reactivation of CMV and hepatitis has been reported, in some cases with fatal outcomes. Consider antiviral therapy to prevent viral reactivation.
Idecabtagene vicleucel (applies to idecabtagene vicleucel) renal/hepatic
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction, Liver Disease
Idecabtagene vicleucel has not been studied in patients with renal or hepatic impairment. Caution is advised.
Switch to professional interaction data
Idecabtagene vicleucel drug interactions
There are 294 drug interactions with idecabtagene vicleucel.
Report options
More about idecabtagene vicleucel
- idecabtagene vicleucel consumer information
- Check interactions
- Compare alternatives
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Darzalex
Darzalex (daratumumab) is a target therapy used to treat multiple myeloma. Includes DARZALEX uses ...
Velcade
Velcade injection is used to treat multiple myeloma and mantle cell lymphoma. Includes Velcade side ...
Pomalyst
Pomalyst (pomalidomide) is used to treat multiple myeloma and AIDS-related Kaposi sarcoma. Includes ...
Kyprolis
KYPROLIS (carfilzomib) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
